344 related articles for article (PubMed ID: 14504874)
21. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
Kirz DS; Haag MK
Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
[TBL] [Abstract][Full Text] [Related]
22. Induction of fetal demise before abortion.
Diedrich J; Drey E;
Contraception; 2010 Jun; 81(6):462-73. PubMed ID: 20472112
[TBL] [Abstract][Full Text] [Related]
23. [Methods of second trimester pregnancy termination and evacuation of in utero dead fetuses. Value of mifepristone].
Maria B; Matheron I
J Gynecol Obstet Biol Reprod (Paris); 1994; 23(6):642-50. PubMed ID: 7995906
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
Kent DR; Goldstein AI; Linzey EM
J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of the efficacy and safety of synthetic prostaglandin E2 derivative and 15-methyl prostaglandin F2 alpha in the termination of midtrimester pregnancy.
Biswas A; Roy S
J Indian Med Assoc; 1996 Aug; 94(8):292-3. PubMed ID: 8855576
[TBL] [Abstract][Full Text] [Related]
26. Midtrimester abortion by hypertonic saline instillation experience in Ramathibodi Hospital.
Suthutvoravut S; Supacharapongkul V; Bhiromswasdi S
J Med Assoc Thai; 1983 Mar; 66(3):176-82. PubMed ID: 6854178
[TBL] [Abstract][Full Text] [Related]
27. Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial.
Yilmaz B; Kelekci S; Ertas IE; Kahyaoglu S; Ozel M; Sut N; Danisman N
Hum Reprod; 2005 Nov; 20(11):3067-71. PubMed ID: 16037107
[TBL] [Abstract][Full Text] [Related]
28. Amniotic fluid adenosine 3',5' - monophosphate in prostaglandin-induced midtrimester abortions.
Weiss PR; Sulimovici S; Macri JN; Robins J; Roginsky MS
Obstet Gynecol; 1977 Feb; 49(2):223-6. PubMed ID: 189262
[TBL] [Abstract][Full Text] [Related]
29. Reproductive performance following midtrimester termination of pregnancy.
Debby A; Glezerman M; Sagiv R; Sadan O; Malinger G; Golan A
Gynecol Obstet Invest; 2003; 56(3):168-72. PubMed ID: 14551459
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 suppositories as a second-trimester abortifacient.
Rakhshani R; Grimes DA
J Reprod Med; 1988 Oct; 33(10):817-20. PubMed ID: 3193412
[TBL] [Abstract][Full Text] [Related]
31. Randomized study on the effect of adding oxytocin to ethacridine lactate or misoprostol for second-trimester termination of pregnancy.
Kelekci S; Erdemoglu E; Inan I
Acta Obstet Gynecol Scand; 2006; 85(7):825-9. PubMed ID: 16817081
[TBL] [Abstract][Full Text] [Related]
32. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
[TBL] [Abstract][Full Text] [Related]
33. Use of intra-amniotic urea as a second trimester abortifacient.
Khare A; Deshmukh MA; Vaidya PR; Sayed A; Companywalla RT; Motashaw ND
J Postgrad Med; 1979 Jul; 25(3):158-61. PubMed ID: 529168
[TBL] [Abstract][Full Text] [Related]
34. Comparison of ethacridine lactate and prostaglandin E2 in second trimester medical abortion.
Inan I; Kelekçi S; Yazar D
Acta Obstet Gynecol Scand; 1997 Aug; 76(7):680-3. PubMed ID: 9292644
[TBL] [Abstract][Full Text] [Related]
35. Midtrimester abortion in patients with a previous uterine scar.
Debby A; Golan A; Sagiv R; Sadan O; Glezerman M
Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):177-80. PubMed ID: 12860337
[TBL] [Abstract][Full Text] [Related]
36. [Second trimester pregnancy termination with and without prostaglandins].
Dimitrova V; Chernev T; Ruseva R; Karagŭozova Zh; Kŭncheva N
Akush Ginekol (Sofiia); 1999; 38(1):3-7. PubMed ID: 11965716
[TBL] [Abstract][Full Text] [Related]
37. Induction of midtrimester abortion with intraamniotic urea, intravenous oxytocin and laminaria.
Golditch IM; Solberg N
J Reprod Med; 1975 Dec; 15(6):225-8. PubMed ID: 1195262
[TBL] [Abstract][Full Text] [Related]
38. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
Verhulsdonk MT; Papatsonis DN; Heydanus R
Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
Colvin J; Bower C; Dickinson JE; Sokol J
Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
Liaquat NF; Javed I; Shuja S; Shoaib T; Bano K; Waheed S; Ansar A
J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
